STAT3 and colorectal carcinoma: Whether HAE also could bind directly to STAT3 has not been investigated to date, at least to the best of our knowledge, but this key target in CRC makes the Amaryllidaceae alkaloids NAR, LYC, and potentially HAE as STAT3 binding agents promising for this specific cancer type.